Richard Doubleday
2017
In 2017, Richard Doubleday earned a total compensation of $2.9M as EVP, Chief Commercial Officer at DexCom, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $389,054 |
|---|---|
| Salary | $355,300 |
| Stock Awards | $2,152,355 |
| Other | $22,446 |
| Total | $2,919,155 |
Doubleday received $2.2M in stock awards, accounting for 74% of the total pay in 2017.
Doubleday also received $389.1K in non-equity incentive plan, $355.3K in salary and $22.4K in other compensation.
Rankings
In 2017, Richard Doubleday's compensation ranked 3,735th out of 14,666 executives tracked by ExecPay. In other words, Doubleday earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,735 out of 14,666 | 75th |
Division Manufacturing | 1,296 out of 5,772 | 78th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 172 out of 859 | 80th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 95 out of 531 | 82nd |
Industry Surgical and Medical Instruments and Apparatus | 60 out of 336 | 82nd |
Source: SEC filing on April 20, 2018.
Doubleday's colleagues
We found eight more compensation records of executives who worked with Richard Doubleday at DexCom in 2017.
2017
Kevin Sayer
DexCom
Chief Executive Officer
2017
Quentin Blackford
DexCom
Chief Financial Officer
2017
Terrance Gregg
DexCom
Chairman
2017
Andrew Balo
DexCom
EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development
2017
Donald Abbey
DexCom
EVP, Quality and Regulatory Affairs
2017
Steven Pacelli
DexCom
EVP, Strategy and Corporate Development
2017
Kevin Sun
DexCom
Chief Financial Officer
2017
Jess Roper
DexCom